Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Emmaus Life Sciences, Inc. | CSO & EVP Clinical Development | Options | 200K | $30K | $0.15 | Feb 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EMMA | Emmaus Life Sciences, Inc. | Feb 1, 2024 | 1 | $30K | 4 | Feb 5, 2024 | CSO & EVP Clinical Development |
EMMA | Emmaus Life Sciences, Inc. | Jan 12, 2023 | 1 | $450K | 4 | Jan 17, 2023 | SVP, Clinical Development |
EMMA | Emmaus Life Sciences, Inc. | Nov 23, 2021 | 0 | $0 | 3 | Dec 28, 2021 | SVP, Clinical Development |